Patient Education Resources

Trusted Partner Education Resources to

Support Patient Care

These educational resources are provided by ACOFP’s trusted partners and are thoughtfully developed to support our members in caring for their patients. Curated with relevance and quality in mind, these offerings complement clinical practice by providing practical, patient-centered education aligned with the needs of osteopathic family physicians.

Materials below include website links, downloadable flyers, infographics, patient toolkits and so much more.

Thank you to our partners for this important collaboration.

AASLD is the leading organization of scientists and health care professionals committed to preventing and curing liver disease. We foster research that leads to improved treatment options for millions of liver disease patients. We advance the science and practice of hepatology through educational conferences, training programs, professional publications, and partnerships with government agencies and sister societies.

The American Academy of Sleep Medicine (AASM) is the only professional society in the U.S. dedicated exclusively to the medical subspecialty of sleep medicine.

The American Diabetes Association (ADA) is the nation’s leading voluntary health organization fighting to end diabetes and helping people thrive. This year, the ADA celebrates 85 years of driving discovery and research to prevent, manage, treat, and ultimately cure diabetes—and we’re not stopping. There are over 155 million Americans living with diabetes or prediabetes. Through advocacy, program development, and education, we’re fighting for them all. 

The American Speech-Language-Hearing Association (ASHA) is the national professional, scientific, and credentialing association for 247,000 members, certificate holders, and affiliates who are audiologists; speech-language pathologists; speech, language, and hearing scientists; audiology and speech-language pathology assistants; and students. Audiologists specialize in preventing and assessing hearing and balance disorders as well as providing audiologic treatment, including hearing aids. Speech-language pathologists (SLPs) identify, assess, and treat speech, language, and swallowing disorders. 

Bristol Myers Squibb Logo

At Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what’s possible for the future of medicine and the patients we serve.

FARE (Food Allergy Research & Education) is the leading nonprofit organization that empowers the food allergy patient across the journey of managing their disease. FARE delivers innovation by focusing on three strategic pillars—research, education, and advocacy. FARE's initiatives strive for a future free from food allergy through effective policies and legislation, novel strategies toward prevention, diagnosis, and treatment, and building awareness and community.

Eli Lilly logo

Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable.

Sitting at the intersection of research, clinical care, patient advocacy, and industry innovation, the American Neuromuscular Foundation (ANF) observed a need to better serve those living with late-onset neuromuscular diseases (LONDs) by bringing the community together and fostering collaboration to improve care, education, and quality of life. This is the rationale for establishing the Late-Onset Neuromuscular Disease Consortium (LONDC).

Merck logo

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. 

Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 68,800 people in 80 countries and markets its products in around 170 countries.

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For 175 years, we have worked to make a difference for all who rely on us. 

The American Sleep Apnea Association (ASAA) was founded in 1990 by people living with sleep apnea, concerned health care providers and researchers as a non-profit 501(c)(3) organization. 

Our mission was simple: The American Sleep Apnea Association is dedicated to reducing injury, disability, and death from sleep apnea and to enhancing the well being of those affected by this common disorder.

Over the years, ASAA became a patient-led organization, leading efforts in education, research, and policy advocacy for sleep apnea and related disorders.

However, people living with sleep apnea are typically not living with sleep apnea alone. In fact, it is common for there to be the presence of other related sleep, medical and psychiatric disorders. Unfortunately, both patients and providers across the globe are frequently unaware of this bidirectional relationship and impact.

THIS BECAME OUR CALL TO ACTION!

Recognizing the growing importance of sleep health, circadian science, and wellness for everyone, we have now evolved our mission. In 2025, ASAA rebranded to reflect our new mission as the Wellness, Sleep and Circadian Network (WSCN).